Reducing day 3 baseline monitoring bloodwork and ultrasound for patients undergoing timed intercourse and intrauterine insemination treatment cycles.
Victoria O'DriscollIlinca GeorgescuIrene KooRebecca ArthurRita ChuangJillian Ann DempseyGiulia De FrancoClaire Ann JonesPublished in: Fertility research and practice (2021)
A significant reduction in IC/IUI treatment cycles that received d3 bloodwork/TVUS was achieved without measured negative treatment impacts. During a pandemic, eliminating routine d3 bloodwork/TVUS represents a safe way to reduce monitoring appointments and exposure.